Aristo Bio-Tech and Lifescience (NSE:ARISTO) EBIT: ₹75 Mil (TTM As of Mar. 2025)

Aristo Bio-Tech and Lifescience  (NSE:ARISTO) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Aristo Bio-Tech and Lifescience's annualized ROC % for the quarter that ended in Mar. 2025 is calculated as:

where

Note: The Operating Income data used here is two times the semi-annual (Mar. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Aristo Bio-Tech and Lifescience's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2025 is calculated as:

where Working Capital is:

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Mar. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Aristo Bio-Tech and Lifescience's Earnings Yield (Joel Greenblatt) % for today is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aristo Bio-Tech and Lifescience EBIT Related Terms

The historical data trend for Aristo Bio-Tech and Lifescience's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aristo Bio-Tech and Lifescience EBIT Chart

Aristo Bio-Tech and Lifescience Semi-Annual Data
	Mar20	Mar21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24	Mar25
EBIT	Get a 7-Day Free Trial				25.73	46.02	27.90	70.89	3.79

NSE:ARISTO vs CTVA, CF: EBIT Comparison

For the Agricultural Inputs subindustry, Aristo Bio-Tech and Lifescience's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aristo Bio-Tech and Lifescience EV-to-EBIT vs Agriculture Industry

For the Agriculture industry and Basic Materials sector, Aristo Bio-Tech and Lifescience's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Aristo Bio-Tech and Lifescience's EV-to-EBIT falls into.

Aristo Bio-Tech and Lifescience EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹75 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aristo Bio-Tech and Lifescience Business Description